Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: Serial comparison with conventional myeloablative transplantation

T. Saito, Y. Kanda, K. Nakai, S. W. Kim, F. Arima, M. Kami, R. Tanosaki, K. Tobinai, H. Wakasugi, Y. Heike, S. Mineishi, Y. Takaue

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The primary object of the conditioning regimen for allogeneic reduced-intensity stem cell transplantation (RIST) is immunosuppression to achieve stable engraftment of donor cells, rather than bone marrow ablation. Therefore, immune reconstitution after RIST might be different from that after conventional stem cell transplantation (CST). In this study, 22 patients underwent RIST and 28 underwent CST. The RIST regimen consisted of cladribine (2-CdA; 0.11 mg/kg/day for 6 days), BU (4 mg/kg/day for 2 days), and rabbit anti-thymocyte globulin (ATG; 2.5 mg/kg/day for 2-4 days). The CST group received either the BU (4 mg/kg/day × 4 days)/CY (60 mg/kg/day × 2 days) (n = 13) or CY (60 mg/kg/day × 2 days)/TBI (4 Gy/day × 3 days) regimen (n = 15). All patients underwent transplantation with G-CSF-mobilize blood stem cells. Engraftment speed after RIST was fast and seven of 22 patients did not require platelet transfusion. We noted that the numbers of CD4+, CD4+ CD45RA+, and CD4+ CD45RO+ T cells after transplant in the RIST group were significantly lower than those in the CST group (P = 0.0001 for both the comparisons). However, the reconstitution of CD20+ B cells was faster in the RIST group (P = 0.0001). The response of T cells to PHA stimulation was lower in the RIST group (P = 0.0001 on day 30 and P = 0.02 on day 90). Nevertheless, there were no significant differences in the incidence of bacterial, fungal, or viral infections between the two groups. We concluded that our RIST regimen might delay laboratory-evaluated T-cell immune reconstitution compared to CST; however, the observed setbacks did not directly translate into clinically significant increases in infectious episodes.

Original languageEnglish (US)
Pages (from-to)601-608
Number of pages8
JournalBone Marrow Transplantation
Volume32
Issue number6
DOIs
StatePublished - Sep 1 2003

Fingerprint

Cladribine
Busulfan
Antilymphocyte Serum
Stem Cell Transplantation
Transplantation
T-Lymphocytes
Platelet Transfusion
Mycoses
Granulocyte Colony-Stimulating Factor
Virus Diseases

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

Saito, T. ; Kanda, Y. ; Nakai, K. ; Kim, S. W. ; Arima, F. ; Kami, M. ; Tanosaki, R. ; Tobinai, K. ; Wakasugi, H. ; Heike, Y. ; Mineishi, S. ; Takaue, Y. / Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin : Serial comparison with conventional myeloablative transplantation. In: Bone Marrow Transplantation. 2003 ; Vol. 32, No. 6. pp. 601-608.
@article{b490d6760a0e4a879f6104a07e4c1b77,
title = "Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: Serial comparison with conventional myeloablative transplantation",
abstract = "The primary object of the conditioning regimen for allogeneic reduced-intensity stem cell transplantation (RIST) is immunosuppression to achieve stable engraftment of donor cells, rather than bone marrow ablation. Therefore, immune reconstitution after RIST might be different from that after conventional stem cell transplantation (CST). In this study, 22 patients underwent RIST and 28 underwent CST. The RIST regimen consisted of cladribine (2-CdA; 0.11 mg/kg/day for 6 days), BU (4 mg/kg/day for 2 days), and rabbit anti-thymocyte globulin (ATG; 2.5 mg/kg/day for 2-4 days). The CST group received either the BU (4 mg/kg/day × 4 days)/CY (60 mg/kg/day × 2 days) (n = 13) or CY (60 mg/kg/day × 2 days)/TBI (4 Gy/day × 3 days) regimen (n = 15). All patients underwent transplantation with G-CSF-mobilize blood stem cells. Engraftment speed after RIST was fast and seven of 22 patients did not require platelet transfusion. We noted that the numbers of CD4+, CD4+ CD45RA+, and CD4+ CD45RO+ T cells after transplant in the RIST group were significantly lower than those in the CST group (P = 0.0001 for both the comparisons). However, the reconstitution of CD20+ B cells was faster in the RIST group (P = 0.0001). The response of T cells to PHA stimulation was lower in the RIST group (P = 0.0001 on day 30 and P = 0.02 on day 90). Nevertheless, there were no significant differences in the incidence of bacterial, fungal, or viral infections between the two groups. We concluded that our RIST regimen might delay laboratory-evaluated T-cell immune reconstitution compared to CST; however, the observed setbacks did not directly translate into clinically significant increases in infectious episodes.",
author = "T. Saito and Y. Kanda and K. Nakai and Kim, {S. W.} and F. Arima and M. Kami and R. Tanosaki and K. Tobinai and H. Wakasugi and Y. Heike and S. Mineishi and Y. Takaue",
year = "2003",
month = "9",
day = "1",
doi = "10.1038/sj.bmt.1704205",
language = "English (US)",
volume = "32",
pages = "601--608",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "6",

}

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin : Serial comparison with conventional myeloablative transplantation. / Saito, T.; Kanda, Y.; Nakai, K.; Kim, S. W.; Arima, F.; Kami, M.; Tanosaki, R.; Tobinai, K.; Wakasugi, H.; Heike, Y.; Mineishi, S.; Takaue, Y.

In: Bone Marrow Transplantation, Vol. 32, No. 6, 01.09.2003, p. 601-608.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin

T2 - Serial comparison with conventional myeloablative transplantation

AU - Saito, T.

AU - Kanda, Y.

AU - Nakai, K.

AU - Kim, S. W.

AU - Arima, F.

AU - Kami, M.

AU - Tanosaki, R.

AU - Tobinai, K.

AU - Wakasugi, H.

AU - Heike, Y.

AU - Mineishi, S.

AU - Takaue, Y.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - The primary object of the conditioning regimen for allogeneic reduced-intensity stem cell transplantation (RIST) is immunosuppression to achieve stable engraftment of donor cells, rather than bone marrow ablation. Therefore, immune reconstitution after RIST might be different from that after conventional stem cell transplantation (CST). In this study, 22 patients underwent RIST and 28 underwent CST. The RIST regimen consisted of cladribine (2-CdA; 0.11 mg/kg/day for 6 days), BU (4 mg/kg/day for 2 days), and rabbit anti-thymocyte globulin (ATG; 2.5 mg/kg/day for 2-4 days). The CST group received either the BU (4 mg/kg/day × 4 days)/CY (60 mg/kg/day × 2 days) (n = 13) or CY (60 mg/kg/day × 2 days)/TBI (4 Gy/day × 3 days) regimen (n = 15). All patients underwent transplantation with G-CSF-mobilize blood stem cells. Engraftment speed after RIST was fast and seven of 22 patients did not require platelet transfusion. We noted that the numbers of CD4+, CD4+ CD45RA+, and CD4+ CD45RO+ T cells after transplant in the RIST group were significantly lower than those in the CST group (P = 0.0001 for both the comparisons). However, the reconstitution of CD20+ B cells was faster in the RIST group (P = 0.0001). The response of T cells to PHA stimulation was lower in the RIST group (P = 0.0001 on day 30 and P = 0.02 on day 90). Nevertheless, there were no significant differences in the incidence of bacterial, fungal, or viral infections between the two groups. We concluded that our RIST regimen might delay laboratory-evaluated T-cell immune reconstitution compared to CST; however, the observed setbacks did not directly translate into clinically significant increases in infectious episodes.

AB - The primary object of the conditioning regimen for allogeneic reduced-intensity stem cell transplantation (RIST) is immunosuppression to achieve stable engraftment of donor cells, rather than bone marrow ablation. Therefore, immune reconstitution after RIST might be different from that after conventional stem cell transplantation (CST). In this study, 22 patients underwent RIST and 28 underwent CST. The RIST regimen consisted of cladribine (2-CdA; 0.11 mg/kg/day for 6 days), BU (4 mg/kg/day for 2 days), and rabbit anti-thymocyte globulin (ATG; 2.5 mg/kg/day for 2-4 days). The CST group received either the BU (4 mg/kg/day × 4 days)/CY (60 mg/kg/day × 2 days) (n = 13) or CY (60 mg/kg/day × 2 days)/TBI (4 Gy/day × 3 days) regimen (n = 15). All patients underwent transplantation with G-CSF-mobilize blood stem cells. Engraftment speed after RIST was fast and seven of 22 patients did not require platelet transfusion. We noted that the numbers of CD4+, CD4+ CD45RA+, and CD4+ CD45RO+ T cells after transplant in the RIST group were significantly lower than those in the CST group (P = 0.0001 for both the comparisons). However, the reconstitution of CD20+ B cells was faster in the RIST group (P = 0.0001). The response of T cells to PHA stimulation was lower in the RIST group (P = 0.0001 on day 30 and P = 0.02 on day 90). Nevertheless, there were no significant differences in the incidence of bacterial, fungal, or viral infections between the two groups. We concluded that our RIST regimen might delay laboratory-evaluated T-cell immune reconstitution compared to CST; however, the observed setbacks did not directly translate into clinically significant increases in infectious episodes.

UR - http://www.scopus.com/inward/record.url?scp=10744232404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744232404&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704205

DO - 10.1038/sj.bmt.1704205

M3 - Article

C2 - 12953133

AN - SCOPUS:10744232404

VL - 32

SP - 601

EP - 608

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 6

ER -